Telemedicine for contraceptive counseling compared to standard care
Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling
This study is testing a new telemedicine service for contraceptive counseling to see if it helps more people in South Africa and Kenya choose long-acting birth control after an abortion compared to regular in-person counseling.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 510 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 2 sites (Cape Town and 1 other locations) |
| Trial ID | NCT06682065 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance access to contraception following abortion by developing and testing a telemedicine service for contraceptive counseling (TECC). It includes a pilot study and a multicenter randomized controlled trial in South Africa and Kenya. The study will evaluate the effectiveness of TECC in increasing the uptake of long-acting reversible contraception (LARC) compared to traditional in-person counseling. Additionally, it will assess user satisfaction, preferences, and rates of unintended pregnancies and abortions following the counseling.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older who are seeking either medical or surgical abortion and have access to a smartphone.
Not a fit: Patients who do not have access to a smartphone or are unable to communicate in English may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve access to contraceptive options for women post-abortion, potentially reducing rates of unintended pregnancies.
How similar studies have performed: Other studies have shown promising results with telemedicine approaches in healthcare, suggesting potential success for this novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
* Seeking either surgical or medical abortion * ≥ 18 years of age * Able to communicate and understand spoken and written English * With private access to a smart phone * Willing to participate in the study procedures
Where this trial is running
Cape Town and 1 other locations
- Michael Mapongwana — Cape Town, South Africa (Recruiting)
- Mitchell´s Plain CHC — Cape Town, South Africa (Recruiting)
Study contacts
- Principal investigator: Margit Endler, PhD — Karolinska Institutet
- Study coordinator: Margit Endler
- Email: margit.endler@ki.se
- Phone: 0789106286
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.